Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll GSK3beta: role in therapeutic landscape and development of modulators Phukan S; Babu VS; Kannoji A; Hariharan R; Balaji VNBr J Pharmacol 2010[May]; 160 (1): 1-19Glycogen synthase kinase-3 beta (GSK3beta) is a multifunctional serine/threonine kinase which was originally identified as a regulator of glycogen metabolism. It plays a key role in the regulation of numerous signalling pathways including cellular process such as cell cycle, inflammation and cell proliferation. Over the last few years there is a considerable rise in the number of journals and patents publication by different workers worldwide. Many pharmaceutical companies are focusing on GSK3beta as a therapeutic target for the treatment of disease conditions. The present review is focused on signalling pathways of different disease conditions where GSK3beta is implicated. In this review, we present a comprehensive map of GSK3beta signalling pathways in disease physiologies. Structural analysis of GSK3beta along with molecular modelling reports from numerous workers are reviewed in context of design and development of GSK3beta inhibitors. Patent landscape of the small molecule modulators is profiled. The chemo space for small molecule modulators extracted from public and proprietary Kinase Chembiobase for GSK3beta are discussed. Compounds in different clinical phases of discovery are analysed. The review ends with the overall status of this important therapeutic target and challenges in development of its modulators.|Amyloid beta-Peptides/physiology[MESH]|Animals[MESH]|Brain-Derived Neurotrophic Factor/physiology[MESH]|Cardiomegaly/drug therapy/metabolism[MESH]|Glycogen Synthase Kinase 3 beta[MESH]|Glycogen Synthase Kinase 3/antagonists & inhibitors/chemistry/*physiology[MESH]|Humans[MESH]|Hypertension/drug therapy/metabolism[MESH]|Insulin/physiology[MESH]|Models, Molecular[MESH]|Neoplasms/drug therapy/metabolism[MESH]|Osteoporosis/drug therapy/metabolism[MESH]|Polymorphism, Single Nucleotide[MESH]|Protein Conformation[MESH]|Signal Transduction[MESH] |